OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
August 11, 2024
Employing novel technologies and more patient-centric approaches can help to reduce the potential of formulation failure.
August 05, 2024
Contract organizations offer sponsors specialized equipment, capacity, and expertise for testing, manufacturing, and packaging bio/pharmaceutical products.
July 23, 2024
The addition of BIOVECTRA’s biologics capabilities to accelerate drug development and manufacturing will allow Agilent to expand its end-to-end offerings for biopharma services.
July 20, 2024
PluriCDMO, Pluri's newly launched CDMO division, has been selected by Kadimastem to manufacture two novel cell therapy product candidates.
July 13, 2024
Thermo Fisher will add Olink to its Life Sciences Solutions business.
July 04, 2024
HCPs are major process-related impurities that must be monitored throughout biologics production for clearance.
July 02, 2024
This collaboration aims to support and accelerate clinical development of advanced and novel technologies.
June 27, 2024
No timetable was given for the length of the planned evaluation or when data would be available, but Kite intends to use the information to expand its manufacturing options.
June 25, 2024
The pairing of Abzena and Argonaut Manufacturing Services is the result of several years’ worth of collaborative work between the two companies.
June 12, 2024
CordenPharma has partnered with Spain-based Certest to develop ionizable lipids for LNP formulations.